Industry - funding opportunities
We work collaboratively with small and medium-sized enterprises to develop funded studies that further test and develop new technologies, providing an evidence-base for adoption. By collaborating, we aim to assist in developing clinically relevant technology, that has a higher chance of uptake and implementation in routine clinical practice.
Studies can be funded externally through schemes such as those below.
If you wish to discuss an opportunity, please get in touch.
Wellcome Trust Innovator Awards
These awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.
Our current focus areas are diagnostics, drug repurposing, mental health, neglected tropical diseases, neurological disorders and rare diseases. We may also consider applications from other areas.
Level of funding: Up to £500,000
Duration of funding: Usually up to 24 months
NIHR Invention for Innovation
As a translational funding scheme, i4i advances healthcare technologies, devices and interventions for increased patient benefit in areas of existing or emerging clinical need.
We fund collaborative R&D projects in medtech SMEs, universities and the NHS that demonstrate proof-of-principle and have a clear pathway towards adoption and commercialisation. The aim is to de-risk projects, making them attractive to follow-on funders and investors.
Product Development Awards:
These awards comprise both early and late stages of R&D including the clinical development of laboratory-validated technologies or interventions. Although no funding limit is imposed, applicants must fully justify all costs. The funding period is for up to three years.
Mental Health Challenge Award:
Applications are invited for the development of innovative technological solutions which can influence the patient care pathway and improve patient outcomes for mental health conditions.